YOLFTbeta
Cambium Bio Ltd

Cambium Bio Ltd

CMB · AU · Healthcare / Biotechnology

0.36AUD-0.04 (-10.00%)

Price History

Full chart

Market Stats

Previous Close0.40
Open0.36
Day Range0.36 – 0.36
52-Week Range0.34 – 0.60
Volume515
Market Cap16.04M
P/E (TTM)0.00
Forward P/E10.58
EPS-0.17
Dividend Yield0.00%
Beta-0.15
50-Day Avg0.4448
200-Day Avg0.4576

About

Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Karolis Rosickas M.B.A., M.S.
  • Employees0
  • HeadquartersUnit 2.06/31 Lexington Dr, Bella Vista, NSW, Australia, 2153, Australia
  • Websitehttps://www.cambium.bio

Leadership

  • Dr. Edmund Kemp Waller FACP, M.D., Ph.D.Chairman & Chief Scientific Officer
  • Mr. Karolis Rosickas M.B.A., M.S.Chief Executive Officer
  • Ms. Olga SmejkalovaCompany Secretary

Financials

Income Statement

Currency: AUD1999-06-302000-06-302001-06-302002-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue158.30M195.14M206.41M201.73M575.00K785.77K1.19M1.72M1.90M1.82M1.74M9.99M575.41K25.08K1.66M7.07M00719670.06K641.64K
Growth (%)-+23.28%+5.77%-2.27%-99.71%+36.65%+50.97%+44.90%+10.65%-4.29%-4.66%+475.87%-94.24%-95.64%+6532.95%+324.87%-100.00%--+93092.77%-4.24%
Cost of Revenue93.32M127.68M151.79M82.06M114.00K187.44K245.73K580.53K621.50K915.40K642.50K381.25K347.96K270.78K--888.80K24.96K6.42K49.21K205.74K62.94K
Gross Profit64.97M67.46M54.63M119.67M-598.33K940.55K1.14M1.28M904.95K1.09M9.61M227.45K-270.78K1.66M7.96M-24.96K-6.42K79.78K464.32K578.70K
Gross Margin41.04%34.57%26.46%59.32%-76.15%79.29%66.23%67.32%49.71%62.98%96.19%39.53%-1079.79%100.00%112.58%--11096.11%69.30%90.19%
Operating Expense23.41M6.09M16.42M17.37M-3.29M6.03M8.68M12.41M10.92M7.54M8.64M7.55M6.59M4.94M6.32M4.63M2.24M1.91M4.76M4.94M
Operating Income41.57M61.37M38.20M102.30M--2.69M-5.09M-7.54M-11.13M-10.02M-6.44M975.58K-7.32M-6.87M-3.28M1.64M-4.65M-2.25M-1.83M-4.30M-4.36M
Operating Margin26.26%31.45%18.51%50.71%--342.73%-428.90%-438.93%-585.18%-550.41%-371.26%9.76%-1271.90%-27376.97%-196.99%23.15%---255131.57%-641.09%-679.11%
EBITDA------2.62M-4.83M-7.00M-10.57M-9.56M-5.96M1.01M-6.94M-6.75M-1.22M2.37M-4.74M-3.09M-1.98M-3.80M-4.36M
EBITDA Margin------333.37%-406.84%-407.43%-555.77%-525.39%-343.15%10.14%-1205.33%-26924.65%-73.35%33.49%---275919.05%-567.76%-679.11%
Net Income15.03M27.42M20.36M-83.19M--1.72M-3.26M-5.20M-7.52M-6.61M-3.57M3.27M-5.18M-6.02M-894.05K2.76M-4.31M-3.38M-2.26M-3.84M-4.10M
Net Income Margin9.49%14.05%9.86%-41.24%--219.21%-274.90%-302.22%-395.53%-362.93%-205.93%32.73%-901.03%-24024.40%-53.75%39.04%---313736.44%-573.72%-638.38%
R&D----82.00K1.79M3.21M4.13M5.76M4.95M4.31M4.46M3.96M2.43M1.18M1.40M1.84M473.42K210.71K2.59M3.02M
R&D as % of Total Revenue----14.26%227.52%270.77%240.52%302.75%271.66%248.31%44.59%687.63%9700.38%70.92%19.82%--29305.70%387.02%470.67%
Interest Expense0000000323.29K349.20K55.45K19.90K16.22K25.86K402.80K271.47K404.50K72.66K290.20K271.20K34.98K13.73K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%18.81%18.36%3.05%1.15%0.16%4.49%1606.25%16.32%5.72%--37718.92%5.22%2.14%

Balance Sheet

Currency: AUD1999-06-302000-06-302001-06-302002-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets281.42M289.37M325.41M50.20M1.82M4.21M3.30M4.02M10.26M9.58M5.93M9.16M4.98M2.54M4.79M8.51M2.55M2.46M5.65M3.30M3.76M
Total Liabilities150.86M128.27M129.20M9.67M450.00K923.21K1.35M6.89M1.95M1.31M1.15M1.06M2.06M8.93M3.70M4.36M1.48M2.59M2.87M1.46M1.38M
Total Equity127.54M155.43M182.74M39.63M1.37M3.29M1.95M-2.87M8.31M8.27M4.78M8.10M2.92M-6.39M1.09M4.15M1.07M-1.81M2.78M1.84M2.38M
Cash42.58M39.10M31.67M33.48M-1.59M528.23K410.66K2.66M3.38M581.47K4.14M1.09M255.46K981.85K3.79M95.12K302.79K2.86M166.41K1.12M
Total Debt-------4.90M742.27K253.37K--1.00M3.78M1.12M13.85K1.01M1.95M468.32K482.71K164.89K
Net Debt------1.59M-528.23K4.49M-1.92M-3.13M-581.47K-4.14M-1.09M3.52M137.12K-3.78M913.25K1.64M-2.40M316.30K-951.27K

Cash Flow

Currency: AUD1999-06-302000-06-302001-06-302002-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow33.43M48.26M38.20M5.43M--1.05M-2.94M-4.62M-6.24M-5.92M-2.25M3.59M-4.25M-3.61M-1.94M2.42M-3.59M-660.46K-155.86K-5.24M-2.81M
Investing Cash Flow-6.91M-8.58M-23.83M72.33M--245.45K-421.46K-399.72K-1.87M260.77K-230.90K-227.46K-150.97K-7.62K41.68K-7.78K-8.47K-48.13K-416.13K-333.48K-322.64K
Financing Cash Flow-6.90M-43.64M-24.75M-67.74M2.05M1.86M2.30M4.90M10.21M6.17M246.73K246.73K1.35M2.78M2.63M400.00K-97.83K916.27K3.13M2.88M4.24M
Capital Expenditure18.35M11.95M20.40M6.01M54.00K237.07K377.86K262.22K1.17M193.01K249.67K149.95K150.97K7.62K7.78K7.78K8.47K445.25K2.64K
Free Cash Flow------1.29M-3.32M-4.88M-7.41M-6.12M-2.50M3.44M-4.40M-3.62M-1.94M2.41M-3.60M-660.46K-155.86K-5.25M-2.81M
Dividends Paid10.00M3.16M3.16M7.11M------00---------
FCF to OCF-----122.56%112.85%105.68%118.83%103.26%111.08%95.82%103.55%100.21%100.00%99.68%100.24%100.00%100.00%100.10%100.09%
Dividend Paid to FCF----------0.00%0.00%---------

Earnings

Report DateFeb 29, 2016Aug 24, 2016Feb 22, 2017Aug 22, 2017Feb 20, 2018Aug 30, 2018Feb 28, 2019Aug 29, 2019Feb 28, 2020Aug 28, 2020Feb 26, 2021Aug 31, 2021Feb 25, 2022Aug 30, 2022Feb 28, 2023
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.00-0.00--
EPS Actual-0.010.000.020.00-0.01-0.01-0.01-0.030.000.000.020.01-0.01-0.01-0.01
Surprise---------------
Timing-------------After-hoursAfter-hours

Key Statistics & Ratios

Market Cap16.04M
Enterprise Value15.22M
Trailing P/E0.00
Forward P/E10.58
Price / Sales13.09
Price / Book6.80
EPS-0.17
Book Value0.087
Revenue (TTM)1.23M
Gross Profit (TTM)1.04M
EBITDA-3.77M
Profit Margin0.00%
Operating Margin-342.53%
Return on Equity-194.37%
Return on Assets-66.82%
Shares Outstanding29.43M
Shares Float3.74M
Beta-0.15
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jul 4, 20241:100